Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg Yothers

Showing results (11-20 of 115) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2013
Colon cancer mutation: prognosis/prediction--responsePatrick G Gavin, Soonmyung Paik, Greg Yothers, et al.
Clinical Trials (London, England)|September 17, 2011
Using cure models and multiple imputation to utilize recurrence as an auxiliary variable for overall survivalAnna S C Conlon, Jeremy M G Taylor, Daniel J Sargent, et al.
Statistics in Medicine|December 21, 2020
On the properties of the toxicity index and its statistical efficiencyZahra S Razaee, Arash A Amini, Márcio A Diniz, et al.
Annals of Surgical Oncology|January 19, 2010
Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trialsNeal W Wilkinson, Greg Yothers, Samia Lopa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2012
Bevacizumab in stage II-III colon cancer: 5-year update of the National Surgical Adjuvant Breast and Bowel Project C-08 trialCarmen J Allegra, Greg Yothers, Michael J O'Connell, et al.
Journal of the National Cancer Institute|November 16, 2006
Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancerJames J Dignam, Blase N Polite, Greg Yothers, et al.
British Journal of Cancer|December 15, 2017
Tumour sidedness and intrinsic subtypes in patients with stage II/III colon cancer: analysis of NSABP C-07 (NRG Oncology)S Rim Kim, Nan Song, Greg Yothers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2011
Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analysesGreg Yothers, Michael J O'Connell, Carmen J Allegra, et al.
JCO Clinical Cancer Informatics|July 16, 2024
Development of a Web-Based Interactive Tool for Visualizing Breast Cancer Clinical Trial Tolerability DataMichael Luu, Gillian Gresham, Lynn Henry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
End points in advanced colon cancer clinical trials: a review and proposalCarmen Allegra, Charles Blanke, Marc Buyse, et al.
Pageof 12

Showing results (11-20 of 115) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2013
Colon cancer mutation: prognosis/prediction--responsePatrick G Gavin, Soonmyung Paik, Greg Yothers, et al.
Clinical Trials (London, England)|September 17, 2011
Using cure models and multiple imputation to utilize recurrence as an auxiliary variable for overall survivalAnna S C Conlon, Jeremy M G Taylor, Daniel J Sargent, et al.
Statistics in Medicine|December 21, 2020
On the properties of the toxicity index and its statistical efficiencyZahra S Razaee, Arash A Amini, Márcio A Diniz, et al.
Annals of Surgical Oncology|January 19, 2010
Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trialsNeal W Wilkinson, Greg Yothers, Samia Lopa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2012
Bevacizumab in stage II-III colon cancer: 5-year update of the National Surgical Adjuvant Breast and Bowel Project C-08 trialCarmen J Allegra, Greg Yothers, Michael J O'Connell, et al.
Journal of the National Cancer Institute|November 16, 2006
Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancerJames J Dignam, Blase N Polite, Greg Yothers, et al.
British Journal of Cancer|December 15, 2017
Tumour sidedness and intrinsic subtypes in patients with stage II/III colon cancer: analysis of NSABP C-07 (NRG Oncology)S Rim Kim, Nan Song, Greg Yothers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2011
Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analysesGreg Yothers, Michael J O'Connell, Carmen J Allegra, et al.
JCO Clinical Cancer Informatics|July 16, 2024
Development of a Web-Based Interactive Tool for Visualizing Breast Cancer Clinical Trial Tolerability DataMichael Luu, Gillian Gresham, Lynn Henry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
End points in advanced colon cancer clinical trials: a review and proposalCarmen Allegra, Charles Blanke, Marc Buyse, et al.
Pageof 12